Outcomes of patients with CML-CP treated with ponatinib vs 2G-TKIs in the third-line setting VJHemOnc – Video Journal of Hematology & HemOnc 2:49 1 year ago 146 Далее Скачать
Ponatinib versus ascimininib in the third-line treatment of CML VJHemOnc – Video Journal of Hematology & HemOnc 1:17 2 years ago 506 Далее Скачать
Vodobatinib in patients with CP-CML who have received ≥ 3 prior TKIs including ponatinib VJHemOnc – Video Journal of Hematology & HemOnc 1:03 2 years ago 159 Далее Скачать
The impact of bariatric surgery on the outcomes of patients with CML treated with TKIs VJHemOnc – Video Journal of Hematology & HemOnc 5:07 2 years ago 122 Далее Скачать
Outcomes of patients with CML with no molecular response within two years of TKI therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:32 1 year ago 805 Далее Скачать
Multidisciplinary management of chronic myeloid leukaemia in the later-line setting Touch Medical Media 46:55 2 years ago 120 Далее Скачать
Ponatinib in chronic-phase CML patients with prior second generation TKI exposure VJHemOnc – Video Journal of Hematology & HemOnc 4:44 4 years ago 323 Далее Скачать
The impact of ponatinib on conception and pregnancy outcomes in patients with CML VJHemOnc – Video Journal of Hematology & HemOnc 2:13 2 weeks ago 62 Далее Скачать
CML - When can treatment stop? - Professor Peter Browett Leukaemia & Blood Cancer New Zealand 41:55 6 years ago 1 217 Далее Скачать
OPTIC: Ponatinib in chronic-phase CML VJHemOnc – Video Journal of Hematology & HemOnc 1:37 3 years ago 255 Далее Скачать
Efficacy and safety of vodobatinib by lines of TKI therapy in Ph+ CML: a subgroup analysis VJHemOnc – Video Journal of Hematology & HemOnc 3:03 2 years ago 93 Далее Скачать
Management of Thrombosis Risk with Ponatinib and other TKIs for CML? HMP Education 24:30 9 years ago 1 258 Далее Скачать
Interim Data Analysis Suggests Ponatinib to be Favorable TKI Treatment Among CML Patients CheckRare 3:51 4 years ago 133 Далее Скачать
Ponatinib for CML and Ph+ ALL: five-year results from the PACE trial VJHemOnc – Video Journal of Hematology & HemOnc 1:16 1 year ago 440 Далее Скачать
Update on ECOG-ACRIN EA9171: pembrolizumab + TKIs in patients with CML and persistent detectable MRD VJHemOnc – Video Journal of Hematology & HemOnc 2:13 2 years ago 126 Далее Скачать
